Computer-Aided Design, Synthesis, and Antiviral Evaluation of Novel Acrylamides as Potential Inhibitors of E3-E2-E1 Glycoproteins Complex from Chikungunya Virus
Chikungunya virus (CHIKV) causes an infectious disease characterized by inflammation and pain of the musculoskeletal tissues accompanied by swelling in the joints and cartilage damage. Currently, there are no licensed vaccines or chemotherapeutic agents to prevent or treat CHIKV infections. In this...
Saved in:
Main Authors: | Gabriel Felipe Silva Passos (Author), Matheus Gabriel Moura Gomes (Author), Thiago Mendonça de Aquino (Author), João Xavier de Araújo-Júnior (Author), Stephannie Janaina Maia de Souza (Author), João Pedro Monteiro Cavalcante (Author), Elane Conceição dos Santos (Author), Ênio José Bassi (Author), Edeildo Ferreira da Silva-Júnior (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current and Promising Antivirals Against Chikungunya Virus
by: Friederike I. L. Hucke, et al.
Published: (2020) -
Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.
by: Petra van den Doel, et al.
Published: (2014) -
Cord blood acrylamide levels and birth size, and interactions with genetic variants in acrylamide-metabolising genes
by: Janneke Hogervorst, et al.
Published: (2021) -
Toxicity of acrylamide and its metabolite - Glicydamide
by: Daria Pingot, et al.
Published: (2013) -
Vitamin A and E Homologues Impacting the Fate of Acrylamide in Equimolar Asparagine-Glucose Model System
by: Su Lee Kuek, et al.
Published: (2021)